Variant position: 270 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 357 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human WVHIDTTPFASLLKNLGTLF GLGLALNSSMYRESCKGKLSK
Mouse WVHLDTTPFASLFKNLGTLL GLGLALNSSMYRKSCKGELSK
Rat WVHLDTTPFASLFKNLGTLL GLGLALNSSMYRKSCKGELRK
Bovine WVHIDTTPFASLLKNLGTLF GLGLALNSSMYRESCKGKLSK
Cat WVHIDTTPFASLLKNVGTLF GLGLALNSSMYRESCKGTLSK
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 357 Glucose-6-phosphatase
255 – 275 Helical
176 – 356 Missing. In isoform 2.
252 – 252 H -> A. Partial loss of catalytic activity.
Molecular aspects of glycogen storage disease type Ia in Turkish patients: a novel mutation in the glucose-6-phosphatase gene.
Huener G.; Podskarbi T.; Schuetz M.; Baykal T.; Sarbat G.; Shin Y.S.; Demirkol M.;
J. Inherit. Metab. Dis. 21:445-446(1998)
Cited for: VARIANTS GSD1A CYS-83; GLN-170 AND TRP-270;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.